“Testing for this biological ‘red flag’ at the same time as other hospital tests identifies those more vulnerable patients who should be receiving closer medical attention.”
Doctor Khamis added: “Importantly, we hope with more research, we can be successful in developing new therapies that specifically combat inflammation to improve outcomes…”
The research project, published in PLOS Medicine – and funded by the BHF – was based on over 250,000 patients who were admitted to hospital with a suspected heart attack.
The data – gathered by the NIHR Health Informatics Collaborative (HIC) – revealed the following.